Climb Bio Inc (CLYM) Directors and Executive Officers

Officers & Directors

Andrew Levin, M.D., Ph.D.
Executive Chairman of the Board of Directors

Adam Rosenberg
Director

Emily Pimblett
Chief Accounting Officer

Simon Tate
Director

Liam Ratcliffe
Director

Judith Dunn
Director

Seattle, Washington ,

Climb Bio Inc currently has 29 employees.

News about Climb Bio Inc Key Personnel

Climb Bio to Unveil Strategic Focus on Immune-Mediated Diseases and Budoprutug Development in Virtual Investor Update,

IntroductionClimb Bio, a biopharmaceutical company, is preparing to share significant updates regarding its lead product candidate, Budoprutug, and its strategic focus on immune-mediated diseases during an upcoming virtual investor event. The transition marks a decisive shift in the company’s operational focus and promises to position Climb Bio as a leader in the development of novel therapies targeting immune-related conditions.Transition to Immune-Mediated Disease FocusAt the heart of Climb Bio s strategy is its commitment to addressing immune-mediated diseases. In recent years, there has been a growing understanding of the complexities around immune response and its link to various chronic conditions su...